CareLit · DOI-Nachweis · Ultraschall in der Medizin - European Journal of Ultrasound
Is digoxin still justifiable as single first-line therapy in fetal supraventricular tachyarrhythmias associated with fetal hydrops?
DOI 10.1055/s-2008-1080842
Bibliografische Angaben
Nachweis in CareLit
Autor:innenDJ Kersten, C Schuller, L Raio, J McDougall, JP Pfammatter, M Meyer-Wittkopf, M Meyer-Wittkopf, D Surbek
ZeitschriftUltraschall in der Medizin - European Journal of Ultrasound
Ausgabe05/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
As long as there is no unanimity in the approach to the drug treatment of fetal tachycardia, digoxin continues to be the most commonly used first-line antiarrhythmic drug. Flecainide, sotalol and amiodarone have emerged as effective second-line treatment after digoxin failure both in nonhydropic and hydropic fetuses. We report five consecutive cases with fetal tachyarrhythmias complicated by hydrops diagnosed and tr…
Zitieren
Zitierempfehlung
DJ Kersten, C Schuller, L Raio, J McDougall, JP Pfammatter, M Meyer-Wittkopf, M Meyer-Wittkopf, D Surbek (2008) Is digoxin still justifiable as single first-line therapy in fetal supraventricular tachyarrhythmias associated with fetal hydrops?. Ultraschall in der Medizin - European Journal of Ultrasound (05). https://doi.org/10.1055/s-2008-1080842
Mit CareLit weiterarbeiten